Skip to main content

Animations

MJFF Publications

3151 - 3160 of 8825 Results
Title
Year
  • Year
  • 2017
  • 2015
  • 2018
  • 2013
  • 2014
  • 2012
  • 2018
  • 2008
  • 2018
  • 2014
  • Summary Details
    OPEN
    Title: Pre-clinical therapeutic development of a series of metalloporphyrins for Parkinson's disease
    Journal Name: Toxicology and Applied Pharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.taap.2017.04.004
    Citation Count: 14
  • Cortical Lewy bodies and Aβ burden are associated with prevalence and timing of dementia in Lewy body diseases
    2015
    Summary Details
    OPEN
    Title: Cortical Lewy bodies and Aβ burden are associated with prevalence and timing of dementia in Lewy body diseases
    Journal Name: Neuropathology and Applied Neurobiology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/nan.12294
    Citation Count: 85
  • Summary Details
    OPEN
    Title: Multitarget transcranial direct current stimulation for freezing of gait in Parkinson's disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27300
    Citation Count: 130
  • Summary Details
    OPEN
    Title: Risky driving and pedunculopontine nucleus-thalamic cholinergic denervation in Parkinson disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2013.08.021
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Association of CD33 polymorphism rs3865444 with Alzheimer's disease pathology and CD33 expression in human cerebral cortex
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.09.023
    Citation Count: 82
  • Summary Details
    OPEN
    Title: Prolonged Maturation Culture Favors a Reduction in the Tumorigenicity and the Dopaminergic Function of Human ESC‐Derived Neural Cells in a Primate Model of Parkinson's Disease
    Journal Name: STEM CELLS
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/stem.1060
    Citation Count: 166
  • Summary Details
    OPEN
    Title: Disease progression models for dominantly-inherited Alzheimer’s disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awy089
    Citation Count: 3
  • The Unified Dyskinesia Rating Scale: Presentation and clinimetric profile
    2008
    Summary Details
    RESTRICTED
    Title: The Unified Dyskinesia Rating Scale: Presentation and clinimetric profile
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.22341
    Citation Count: 231
  • Summary Details
    OPEN
    Title: Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer’s disease
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00401-018-1948-2
    Citation Count: 167
  • Summary Details
    OPEN
    Title: Tremor in Spinocerebellar Ataxia Type 12
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.12015
    Citation Count: 9
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.